The number of people with susceptibility test result for rifampicin in Guatemala
Guatemala: The number of people with susceptibility test result for rifampicin was 95.02 in 2021. ▲ Rising
Latest (2021)
95.02
Change on year
up 172.8%
World rank
51st
of 146 countries
All-time high
95.02
in 2021
All-time low
29.15
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Guatemala, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Guatemala stood at 95.02. That is the highest value across all 5 years on record.
That represents a change of up 172.8% on the previous year and up 191.4% over five years.
That places Guatemala 51st out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Guatemala, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 32.61 | — |
| 2018 | 29.15 | -10.6% |
| 2019 | 68.3 | +134.3% |
| 2020 | 34.83 | -49.0% |
| 2021 | 95.02 | +172.8% |
Guatemala compared with similar countries
- Guatemala's 95.02 is above the median for upper middle income countries, which is 92.7, 1.0× the median. (45 countries reporting)
- Guatemala's 95.02 is above the median for Latin America & Caribbean, which is 59.38, 1.6× the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 43.35 | 29.15 | 68.3 | 3 |
| 2020s | 64.93 | 34.83 | 95.02 | 2 |
Countries ranked near Guatemala
More health data for Guatemala
- Un projection of annual infant deaths, annual growth rate -1.92 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7968 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,202 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,022 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.4059 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0487 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.3488 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Guatemala?
- The number of people with susceptibility test result for rifampicin in Guatemala was 95.02 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Guatemala?
- The highest recorded value was 95.02 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Guatemala?
- The lowest recorded value was 29.15 in 2018.
- How does Guatemala rank for the number of people with susceptibility test result for rifampicin?
- Guatemala ranks 51st out of 146 countries with data for 2021.
- Where does this Guatemala data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).